TTRX
Turn·NASDAQ
--
--(--)
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TTRX
Turn Therapeutics Inc.
Dedicated to improving healthcare systems in low-and middle-income countries
Life Science Tools and Services
01/06/2015
10/08/2025
NASDAQ Stock Exchange
2
12-31
Common stock
250 N. Westlake Blvd.
Westlake Village
CA 91362
--
Turn Therapeutics Inc., originally formed on January 6, 2015, is a Delaware limited liability company. The company is a pharmaceutical and medical device development company with core technologies based on proprietary platforms designed to enhance drug performance. Its patented blending process — commercially known as PermaFusion — enables the stable suspension of polar water-soluble active pharmaceutical ingredients (" APIs ") in oily carriers without the use of emulsifiers. Its main development projects focus on skin diseases, including moderate to severe eczema and onychomycosis.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
